Ellen W Collisson

Title: Ellen W Collisson: Innovator in Feline Immunology

Introduction

Ellen W Collisson is a prominent inventor based in College Station, TX (US). She has made significant contributions to the field of feline immunology, holding a total of 4 patents. Her work focuses on the development of vaccines and therapeutic agents that enhance immune responses in felines.

Latest Patents

Collisson's latest patents include groundbreaking inventions related to feline CD86 polypeptides and nucleic acids. These inventions provide isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, and feline CTLA-4 (CD152) receptor. The patents also describe vectors comprising nucleic acid encoding these important proteins. Furthermore, her inventions detail host cells transformed with CD80-encoding vectors, CD86-encoding vectors, CD28-encoding vectors, or CTLA-4-encoding vectors. The vaccines developed from her research are designed to enhance immune responses and can also suppress unwanted immune reactions.

Career Highlights

Throughout her career, Ellen W Collisson has worked with notable organizations such as the Texas A&M University System and Intervet Inc. Her research has significantly advanced the understanding of feline immunology and has the potential to improve the health and well-being of cats worldwide.

Collaborations

Collisson has collaborated with esteemed colleagues, including Barbara J Winslow and Mark D Cochran. These partnerships have fostered innovation and have contributed to the success of her research endeavors.

Conclusion

Ellen W Collisson is a distinguished inventor whose work in feline immunology has led to important advancements in vaccine development. Her contributions continue to impact the field positively, enhancing the health of felines through innovative solutions.